Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Krähenbühl S[au]:

Medikamentöse Hepatopathien. Krähenbühl S et al. Ther Umsch. (2017)

Leucopenia associated with metamizole: a case-control study. Blaser L et al. Swiss Med Wkly. (2017)

Lifestyle-Medikamente: Vergnügen ohne Ende? Krähenbühl S et al. Ther Umsch. (2016)

Search results

Items: 1 to 50 of 355

1.

PGC-1α plays a pivotal role in simvastatin-induced exercise impairment in mice.

Panajatovic MV, Singh F, Roos NJ, Duthaler U, Handschin C, Krähenbühl S, Bouitbir J.

Acta Physiol (Oxf). 2019 Oct 12. doi: 10.1111/apha.13402. [Epub ahead of print]

PMID:
31605661
2.

ELIMU-MDx: a web-based, open-source platform for storage, management and analysis of diagnostic qPCR data.

Krähenbühl S, Studer F, Guirou E, Deal A, Mächler P, Hosch S, Mpina M, Mswata S, Daubenberger C, Schindler T.

Biotechniques. 2019 Oct 7. doi: 10.2144/btn-2019-0064. [Epub ahead of print]

3.

Exogenous Iron Increases Fasciocidal Activity and Hepatocellular Toxicity of the Synthetic Endoperoxides OZ78 and MT04.

Brecht K, Kirchhofer C, Bouitbir J, Trapani F, Keiser J, Krähenbühl S.

Int J Mol Sci. 2019 Oct 1;20(19). pii: E4880. doi: 10.3390/ijms20194880.

4.

Acute Liver Failure in a Patient Treated With Metamizole.

Krisai P, Rudin D, Grünig D, Scherer K, Pichler W, Terracciano L, Krähenbühl S.

Front Pharmacol. 2019 Sep 11;10:996. doi: 10.3389/fphar.2019.00996. eCollection 2019.

5.

Mitochondrial oxidative stress plays a critical role in the cardiotoxicity of sunitinib: Running title: Sunitinib and oxidative stress in hearts.

Bouitbir J, Alshaikhali A, Panajatovic MV, Abegg VF, Paech F, Krähenbühl S.

Toxicology. 2019 Oct 1;426:152281. doi: 10.1016/j.tox.2019.152281. Epub 2019 Aug 22.

PMID:
31445075
6.

Metamizole-associated neutropenia: Comparison of patients with neutropenia and metamizole-tolerant patients.

Rudin D, Spoendlin J, Cismaru AL, Liakoni E, Bonadies N, Amstutz U, Meier CR, Krähenbühl S, Haschke M.

Eur J Intern Med. 2019 Oct;68:36-43. doi: 10.1016/j.ejim.2019.07.029. Epub 2019 Aug 3.

PMID:
31383393
7.

Toxicity of metamizole on differentiating HL60 cells and human neutrophil granulocytes.

Rudin D, Roos NJ, Duthaler U, Krähenbühl S.

Toxicology. 2019 Oct 1;426:152254. doi: 10.1016/j.tox.2019.152254. Epub 2019 Jul 26.

PMID:
31356851
8.

Decrease in Antibacterial Use and Facility-Level Variability After the Introduction of Guidelines and Implementation of Physician-Pharmacist-Nurse Quality Circles in Swiss Long-term Care Facilities.

Plüss-Suard C, Niquille A, Héquet D, Krähenbühl S, Pichon R, Zanetti G, Bugnon O, Petignat C.

J Am Med Dir Assoc. 2019 Jul 18. pii: S1525-8610(19)30442-6. doi: 10.1016/j.jamda.2019.05.016. [Epub ahead of print]

PMID:
31327571
9.

Sex differences in the pharmacology of itch therapies-a narrative review.

Schmid Y, Navarini A, Thomas ZM, Pfleiderer B, Krähenbühl S, Mueller SM.

Curr Opin Pharmacol. 2019 Jun;46:122-142. doi: 10.1016/j.coph.2019.05.008. Epub 2019 Jul 9. Review.

PMID:
31299512
10.

Hepatotoxicity Due to Azole Antimycotic Agents in a HLA B*35:02-Positive Patient.

Bühler T, Medinger M, Bouitbir J, Krähenbühl S, Leuppi-Taegtmeyer A.

Front Pharmacol. 2019 Jun 11;10:645. doi: 10.3389/fphar.2019.00645. eCollection 2019.

11.

OATP1B3-1B7 (LST-3TM12) Is a Drug Transporter That Affects Endoplasmic Reticulum Access and the Metabolism of Ezetimibe.

Malagnino V, Duthaler U, Seibert I, Krähenbühl S, Meyer Zu Schwabedissen HE.

Mol Pharmacol. 2019 Aug;96(2):128-137. doi: 10.1124/mol.118.114934. Epub 2019 May 24.

PMID:
31127008
12.

Microdosed midazolam for the determination of cytochrome P450 3A activity: Development and clinical evaluation of a buccal film.

Kiene K, Hayasi N, Burhenne J, Uchitomi R, Sünderhauf C, Schmid Y, Haschke M, Haefeli WE, Krähenbühl S, Mikus G, Inada H, Huwyler J.

Eur J Pharm Sci. 2019 Jul 1;135:77-82. doi: 10.1016/j.ejps.2019.05.010. Epub 2019 May 16.

PMID:
31102650
13.

Insulin prevents and reverts simvastatin-induced toxicity in C2C12 skeletal muscle cells.

Sanvee GM, Bouitbir J, Krähenbühl S.

Sci Rep. 2019 May 15;9(1):7409. doi: 10.1038/s41598-019-43938-5.

14.

Para-Halogenation Affects Monoamine Transporter Inhibition Properties and Hepatocellular Toxicity of Amphetamines and Methcathinones.

Luethi D, Walter M, Zhou X, Rudin D, Krähenbühl S, Liechti ME.

Front Pharmacol. 2019 Apr 24;10:438. doi: 10.3389/fphar.2019.00438. eCollection 2019.

15.

Reconstruction of Spinal Soft Tissue Defects With Perforator Flaps From the Paraspinal Region.

DI Summa PG, Largo RD, Ismail T, Tremp M, Lunger A, Wettstein R, Krähenbühl SM, Giordano S, Schaefer DJ, Schaeren S, Kalbermatten DF.

In Vivo. 2019 May-Jun;33(3):827-832. doi: 10.21873/invivo.11546.

16.

Gait analysis following single-shot hyaluronic acid supplementation: a pilot randomized double-blinded controlled trial.

Pereira LC, Schweizer C, Moufarrij S, Krähenbühl SM, Favre J, Gremion G, Applegate LA, Jolles BM.

Pilot Feasibility Stud. 2019 Apr 22;5:56. doi: 10.1186/s40814-019-0443-4. eCollection 2019.

17.

Development and validation of an LC-MS/MS method for the analysis of ivermectin in plasma, whole blood, and dried blood spots using a fully automatic extraction system.

Duthaler U, Suenderhauf C, Gaugler S, Vetter B, Krähenbühl S, Hammann F.

J Pharm Biomed Anal. 2019 Aug 5;172:18-25. doi: 10.1016/j.jpba.2019.04.007. Epub 2019 Apr 16.

PMID:
31015095
18.

Cytochrome P450 enzymes contribute to the metabolism of LSD to nor-LSD and 2-oxo-3-hydroxy-LSD: Implications for clinical LSD use.

Luethi D, Hoener MC, Krähenbühl S, Liechti ME, Duthaler U.

Biochem Pharmacol. 2019 Jun;164:129-138. doi: 10.1016/j.bcp.2019.04.013. Epub 2019 Apr 11.

PMID:
30981875
19.

Molecular Toxicological Mechanisms of Synthetic Cathinones on C2C12 Myoblasts.

Zhou X, Luethi D, Sanvee GM, Bouitbir J, Liechti ME, Krähenbühl S.

Int J Mol Sci. 2019 Mar 28;20(7). pii: E1561. doi: 10.3390/ijms20071561.

20.

Mechanisms of statin-associated skeletal muscle-associated symptoms.

Bouitbir J, Sanvee GM, Panajatovic MV, Singh F, Krähenbühl S.

Pharmacol Res. 2019 Mar 12:104201. doi: 10.1016/j.phrs.2019.03.010. [Epub ahead of print] Review.

PMID:
30877064
21.

Application of New Cellular and Microphysiological Systems to Drug Metabolism Optimization and Their Positioning Respective to In Silico Tools.

Docci L, Parrott N, Krähenbühl S, Fowler S.

SLAS Discov. 2019 Jun;24(5):523-536. doi: 10.1177/2472555219831407. Epub 2019 Feb 28.

PMID:
30817893
22.

Mechanisms of insulin resistance by simvastatin in C2C12 myotubes and in mouse skeletal muscle.

Sanvee GM, Panajatovic MV, Bouitbir J, Krähenbühl S.

Biochem Pharmacol. 2019 Jun;164:23-33. doi: 10.1016/j.bcp.2019.02.025. Epub 2019 Feb 20.

PMID:
30796916
23.

No Clinically Relevant Interactions of St. John's Wort Extract Ze 117 Low in Hyperforin With Cytochrome P450 Enzymes and P-glycoprotein.

Zahner C, Kruttschnitt E, Uricher J, Lissy M, Hirsch M, Nicolussi S, Krähenbühl S, Drewe J.

Clin Pharmacol Ther. 2019 Aug;106(2):432-440. doi: 10.1002/cpt.1392. Epub 2019 Mar 23.

24.

Metabolism of the Dual Orexin Receptor Antagonist ACT-541468, Based on Microtracer/ Accelerator Mass Spectrometry.

Muehlan C, Fischer H, Zimmer D, Aissaoui H, Grimont J, Boss C, Croft M, van Gerven J, Krähenbühl S, Dingemanse J.

Curr Drug Metab. 2019;20(4):254-265. doi: 10.2174/1389200220666190206141814.

PMID:
30727881
25.

Prognostic impact of polypharmacy and drug interactions in patients with advanced cancer.

Hoemme A, Barth H, Haschke M, Krähenbühl S, Strasser F, Lehner C, von Kameke A, Wälti T, Thürlimann B, Früh M, Driessen C, Joerger M.

Cancer Chemother Pharmacol. 2019 Apr;83(4):763-774. doi: 10.1007/s00280-019-03783-9. Epub 2019 Jan 25.

PMID:
30684020
26.

Non-immunological toxicological mechanisms of metamizole-associated neutropenia in HL60 cells.

Rudin D, Lanzilotto A, Bachmann F, Housecroft CE, Constable EC, Drewe J, Haschke M, Krähenbühl S.

Biochem Pharmacol. 2019 May;163:345-356. doi: 10.1016/j.bcp.2019.01.011. Epub 2019 Jan 14.

PMID:
30653950
27.

Comment on "Incidence of risk factors for bloodstream infections in patients with major burns receiving intensive care: A retrospective single-center cohort study".

Krähenbühl SM, Pantet O, Berger MM, Raffoul W, di Summa PG.

Burns. 2019 May;45(3):743-744. doi: 10.1016/j.burns.2018.10.028. Epub 2018 Dec 28. No abstract available.

PMID:
30598267
28.

Population pharmacokinetics of oral ivermectin in venous plasma and dried blood spots in healthy volunteers.

Duthaler U, Suenderhauf C, Karlsson MO, Hussner J, Meyer Zu Schwabedissen H, Krähenbühl S, Hammann F.

Br J Clin Pharmacol. 2019 Mar;85(3):626-633. doi: 10.1111/bcp.13840. Epub 2019 Jan 24.

PMID:
30566757
29.

PGC-1β modulates statin-associated myotoxicity in mice.

Singh F, Zoll J, Duthaler U, Charles AL, Panajatovic MV, Laverny G, McWilliams TG, Metzger D, Geny B, Krähenbühl S, Bouitbir J.

Arch Toxicol. 2019 Feb;93(2):487-504. doi: 10.1007/s00204-018-2369-7. Epub 2018 Dec 3.

PMID:
30511338
30.

Comparison of Rat and Human Pulmonary Metabolism Using Precision-cut Lung Slices (PCLS).

Yilmaz Y, Williams G, Walles M, Manevski N, Krähenbühl S, Camenisch G.

Drug Metab Lett. 2019;13(1):53-63. doi: 10.2174/1872312812666181022114622.

PMID:
30345935
31.

The hepatotoxic potential of protein kinase inhibitors predicted with Random Forest and Artificial Neural Networks.

Schöning V, Krähenbühl S, Drewe J.

Toxicol Lett. 2018 Dec 15;299:145-148. doi: 10.1016/j.toxlet.2018.10.009. Epub 2018 Oct 10.

PMID:
30315951
32.

Pharmacokinetics of oxycodone/naloxone and its metabolites in patients with end-stage renal disease during and between haemodialysis sessions.

Leuppi-Taegtmeyer A, Duthaler U, Hammann F, Schmid Y, Dickenmann M, Amico P, Jehle AW, Kalbermatter S, Lenherr C, Meyer Zu Schwabedissen HE, Haschke M, Liechti ME, Krähenbühl S.

Nephrol Dial Transplant. 2019 Apr 1;34(4):692-702. doi: 10.1093/ndt/gfy285.

PMID:
30189012
33.

Cytochrome P450 Enzymes Involved in Metoprolol Metabolism and Use of Metoprolol as a CYP2D6 Phenotyping Probe Drug.

Berger B, Bachmann F, Duthaler U, Krähenbühl S, Haschke M.

Front Pharmacol. 2018 Jul 24;9:774. doi: 10.3389/fphar.2018.00774. eCollection 2018.

34.

Using dried blood spots to facilitate therapeutic drug monitoring of antiretroviral drugs in resource-poor regions.

Duthaler U, Berger B, Erb S, Battegay M, Letang E, Gaugler S, Natamatungiro A, Mnzava D, Donzelli M, Krähenbühl S, Haschke M.

J Antimicrob Chemother. 2018 Oct 1;73(10):2729-2737. doi: 10.1093/jac/dky254.

PMID:
30052975
35.

Sunitinib induces hepatocyte mitochondrial damage and apoptosis in mice.

Paech F, Abegg VF, Duthaler U, Terracciano L, Bouitbir J, Krähenbühl S.

Toxicology. 2018 Nov 1;409:13-23. doi: 10.1016/j.tox.2018.07.009. Epub 2018 Jul 18.

PMID:
30031043
36.

Effect of temporal onsets of mechanical loading on bone formation inside a tissue engineering scaffold combined with cell therapy.

Hausherr TC, Nuss K, Thein E, Krähenbühl S, Applegate LA, Pioletti DP.

Bone Rep. 2018 Apr 26;8:173-179. doi: 10.1016/j.bonr.2018.04.008. eCollection 2018 Jun.

37.

Prediction of Safety Margin and Optimization of Dosing Protocol for a Novel Antibiotic using Quantitative Systems Pharmacology Modeling.

Woodhead JL, Paech F, Maurer M, Engelhardt M, Schmitt-Hoffmann AH, Spickermann J, Messner S, Wind M, Witschi AT, Krähenbühl S, Siler SQ, Watkins PB, Howell BA.

Clin Transl Sci. 2018 Sep;11(5):498-505. doi: 10.1111/cts.12560. Epub 2018 Jun 7.

38.

N-demethylation of N-methyl-4-aminoantipyrine, the main metabolite of metamizole.

Bachmann F, Duthaler U, Rudin D, Krähenbühl S, Haschke M.

Eur J Pharm Sci. 2018 Jul 30;120:172-180. doi: 10.1016/j.ejps.2018.05.003. Epub 2018 May 8.

PMID:
29746911
39.

Effect of Toxicants on Fatty Acid Metabolism in HepG2 Cells.

Grünig D, Duthaler U, Krähenbühl S.

Front Pharmacol. 2018 Apr 23;9:257. doi: 10.3389/fphar.2018.00257. eCollection 2018.

40.

Functional assessment of rat pulmonary flavin-containing monooxygenase activity.

Yilmaz Y, Williams G, Manevski N, Walles M, Krähenbühl S, Camenisch G.

Xenobiotica. 2019 May;49(5):503-512. doi: 10.1080/00498254.2018.1469804. Epub 2018 May 15.

PMID:
29694257
41.

Effect of the Catechol-O-Methyltransferase Inhibitors Tolcapone and Entacapone on Fatty Acid Metabolism in HepaRG Cells.

Grünig D, Felser A, Duthaler U, Bouitbir J, Krähenbühl S.

Toxicol Sci. 2018 Aug 1;164(2):477-488. doi: 10.1093/toxsci/kfy101.

PMID:
29688484
42.

Management of bilateral necrotizing bronchial dehiscence after a double lung transplantation.

Krahenbuhl SM, Gonzalez M, Aubert JD, Tamm M, Ris HB, Krueger T, Perentes JY.

J Thorac Cardiovasc Surg. 2018 Jul;156(1):e29-e31. doi: 10.1016/j.jtcvs.2018.02.070. Epub 2018 Mar 8. No abstract available.

PMID:
29609884
43.

Psychoactive substances and violent offences: A retrospective analysis of presentations to an urban emergency department in Switzerland.

Liakoni E, Gartwyl F, Ricklin M, Exadaktylos AK, Krähenbühl S.

PLoS One. 2018 Mar 29;13(3):e0195234. doi: 10.1371/journal.pone.0195234. eCollection 2018.

44.

Mechanisms of mitochondrial toxicity of the kinase inhibitors ponatinib, regorafenib and sorafenib in human hepatic HepG2 cells.

Paech F, Mingard C, Grünig D, Abegg VF, Bouitbir J, Krähenbühl S.

Toxicology. 2018 Feb 15;395:34-44. doi: 10.1016/j.tox.2018.01.005. Epub 2018 Jan 16.

PMID:
29341879
45.

The Views of Ex-Police Officers on Child Abuse Case Attrition in the United Kingdom.

Krahenbuhl SJ, Dent HR.

J Interpers Violence. 2017 Nov 1:886260517744763. doi: 10.1177/0886260517744763. [Epub ahead of print]

PMID:
29295014
46.

Mechanisms of toxicity associated with six tyrosine kinase inhibitors in human hepatocyte cell lines.

Mingard C, Paech F, Bouitbir J, Krähenbühl S.

J Appl Toxicol. 2018 Mar;38(3):418-431. doi: 10.1002/jat.3551. Epub 2017 Oct 26.

PMID:
29072336
47.

Pharmacological profile of methylphenidate-based designer drugs.

Luethi D, Kaeser PJ, Brandt SD, Krähenbühl S, Hoener MC, Liechti ME.

Neuropharmacology. 2018 May 15;134(Pt A):133-140. doi: 10.1016/j.neuropharm.2017.08.020. Epub 2017 Aug 18.

PMID:
28823611
48.

Medikamentöse Hepatopathien.

Krähenbühl S, Pichler WJ.

Ther Umsch. 2017 Jul;74(3):123-130. doi: 10.1024/0040-5930/a000895. Review. German. No abstract available.

PMID:
28777047
49.

An alternative sterility assessment for parenteral drug products using isothermal microcalorimetry.

Brueckner D, Krähenbühl S, Zuber U, Bonkat G, Braissant O.

J Appl Microbiol. 2017 Sep;123(3):773-779. doi: 10.1111/jam.13520. Epub 2017 Aug 4.

PMID:
28776899
50.

Recreational use of carfentanil - a case report with laboratory confirmation.

Müller S, Nussbaumer S, Plitzko G, Ludwig R, Weinmann W, Krähenbühl S, Liakoni E.

Clin Toxicol (Phila). 2018 Feb;56(2):151-152. doi: 10.1080/15563650.2017.1355464. Epub 2017 Jul 31. No abstract available.

PMID:
28756689

Supplemental Content

Loading ...
Support Center